£1.7m awarded to University of Surrey for research into neurological diseases
The University of Surrey has successfully secured a £1.7million from the European Joint Programme for Neurodegenerative Disease Research to spearhead pioneering research into neurological illnesses.
Working with researchers from Canada, Germany, Sweden and Germany, scientists from the University of Surrey will lead the international NEURONODE Project, which will investigate the onset of neurodegenerative diseases. Focusing on a combination of prevalent and rare neurological diseases, including Parkinson's, Alzheimer, ALS and Batten’s disease, researchers will work to develop innovative diagnostics and tests to identify early onset of neurological ailments. This will help pave the way for early diagnosis of such diseases.
Project Coordinator Dr Peter McCormick, Senior Lecturer in Neuroscience, at the School of Veterinary Medicine at the University of Surrey, said: “While neurodegenerative diseases manifest themselves in different ways, we think common regulatory nodes can exist between them in brain cells.
“This funding will help us investigate this further and, if successful, this could lead to earlier diagnosis of neurological diseases helping people get earlier more effective treatment.
“Leading this project is a tremendous honour and is recognition of Surrey as a centre of excellence in this field.”
Dr Nicolas Locker, Senior Lecturer in Virology at the University of Surrey, said: “I am delighted that we have received this important funding to develop the NEURONODE project.
“Neurological illnesses have devastating effects on both patients and families but they are often difficult to diagnose. This project will help us develop innovative tests to give clear answers to patients on their condition.”
Latest figures from the Neurological Alliance show that 12.5 million people in England are now suffering from a neurological disease, putting additional pressure on the NHS and social care system. An estimated £2.4 billion is spent each year on social care services for people with a neurological disease.